(2-Methylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)methanamine

Catalog No. :
ACBLCD284
CAS No. :
933734-68-0
Molecular Formula :
C6H8N4S
Molecular Weight :
168.23

IUPAC Name:(2-methylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)methanamine

(2-Methylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$268.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-Methylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)methanamine
IUPAC Name(2-methylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)methanamine
MDL No.MFCD09971159
Molecular FormulaC6H8N4S
Molecular Weight168.23
SMILESNCC1=CN2C(SC(C)=N2)=N1
InChI KeyGKNHWJKAWRNGHA-UHFFFAOYSA-N
Synonym[(2-Methylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)-methyl]amine dihydrochloride;(2-methylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)methanamine;(2-methylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)methanamine:hydrate:dihydrochloride;Imidazo[2,1-b]-1,3,4-thiadiazole-6-methanamine, 2-methyl-;(2-Methylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)methylamine;(2-Methylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)methanamine - [M89005]
CAS No.933734-68-0

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACBLCD284 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBLCD284 route product structure diagram
    ACBLCD284933734-68-0 In Stock
Inquiry

2. ACBLCD284 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBLCD284 route product structure diagram
    ACBLCD284933734-68-0 In Stock
Inquiry

Comments (0)